Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did Aardvark Therapeutics Beat Earnings?

Aardvark Therapeutics (AARD) reported Q2 '26 revenue of $0.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Aardvark Therapeutics’s job postings, web traffic, and employee business outlook. See the full AARD stock analysis or the earnings calendar for upcoming reports.

Aardvark Therapeutics Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue————————
Gross margin————————
Operating margin————————
Net income-4.2M-8.8M-9.3M-14M-16M-18M-22M-14M
Net margin————————
EPS————————

Aardvark Therapeutics Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Aardvark Therapeutics’s quarterly revenue moved from $0 to $0.

When Is Aardvark Therapeutics’s Next Earnings Date?

Aardvark Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the AARD earnings calendar.

Frequently Asked Questions: Aardvark Therapeutics Earnings

Aardvark Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Aardvark Therapeutics reported Q2 '26 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the AARD AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.